BRAF-/MEK-Inhibition With Dabrafenib and Trametinib in Melanoma Patients
Clinical trial NCT03944356 · COMPLETED
Trial details
- NCT number
- NCT03944356
- Sponsor
- EuMelaReg gGmbH
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-07-01
- Primary completion
- 2023-12-31
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.